These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31196644)

  • 1. Preventing Rheumatoid Arthritis: A Global Challenge.
    Widdifield J
    Clin Ther; 2019 Jul; 41(7):1355-1365. PubMed ID: 31196644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid Arthritis.
    Costello R; David T; Jani M
    Clin Ther; 2019 Jul; 41(7):1376-1396. PubMed ID: 31196653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.
    Demoruelle MK; Deane KD
    Curr Rheumatol Rep; 2012 Oct; 14(5):472-80. PubMed ID: 22773387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the prevention of rheumatoid arthritis possible?
    Alpizar-Rodriguez D; Finckh A
    Clin Rheumatol; 2020 May; 39(5):1383-1389. PubMed ID: 32016656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.
    Finckh A; Escher M; Liang MH; Bansback N
    Curr Rheumatol Rep; 2016 Aug; 18(8):51. PubMed ID: 27402108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid Arthritis: A Severe Disease That Preventive Approaches Would Greatly Benefit.
    Davis JM
    Clin Ther; 2019 Jul; 41(7):1240-1245. PubMed ID: 31196648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis.
    Falahee M; Finckh A; Raza K; Harrison M
    Clin Ther; 2019 Jul; 41(7):1346-1354. PubMed ID: 31196645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.
    Hilliquin S; Hugues B; Mitrovic S; Gossec L; Fautrel B
    Ann Rheum Dis; 2018 Aug; 77(8):1099-1106. PubMed ID: 29884751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can rheumatoid arthritis be prevented?
    Deane KD
    Best Pract Res Clin Rheumatol; 2013 Aug; 27(4):467-85. PubMed ID: 24315049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing the progression from undifferentiated arthritis to rheumatoid arthritis: the clinical and economic implications.
    Schiff MH
    Am J Manag Care; 2010 Nov; 16(9 Suppl):S243-8. PubMed ID: 21517637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text.
    Ford E; Carroll J; Smith H; Davies K; Koeling R; Petersen I; Rait G; Cassell J
    BMJ Open; 2016 Jun; 6(6):e010393. PubMed ID: 27354069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief Report: Clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: A Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example.
    Burgers LE; Allaart CF; Huizinga TWJ; van der Helm-van Mil AHM
    Arthritis Rheumatol; 2017 May; 69(5):926-931. PubMed ID: 28217975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk.
    Myasoedova E
    Curr Opin Rheumatol; 2017 May; 29(3):277-284. PubMed ID: 28207495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies in preclinical stages of rheumatoid arthritis.
    Schulz N; Lange U; Klemm P
    Pol Arch Intern Med; 2024 Jun; 134(6):. PubMed ID: 38832902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early inflammatory arthritis versus rheumatoid arthritis.
    Finckh A
    Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.
    van Nies JA; Tsonaka R; Gaujoux-Viala C; Fautrel B; van der Helm-van Mil AH
    Ann Rheum Dis; 2015 May; 74(5):806-12. PubMed ID: 25561360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
    Gerlag DM; Norris JM; Tak PP
    Rheumatology (Oxford); 2016 Apr; 55(4):607-14. PubMed ID: 26374913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.